Quick Links
Past Events

Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Incyte.

Privacy Policy
Terms & Conditions
Executive Board
Faculty Portal
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

ASH: Addressing Post-Transplant Obstacles: Current and Emerging Strategies to Evolve the Standard of Care for Patients with GvHD

ASH: Addressing Post-Transplant Obstacles: Current and Emerging Strategies to Evolve the Standard of Care for Patients with GvHD

December 8, 2017
Lunch and registration: 12:30 PM – 1:30 PM

Georgia World Congress Center
Lunch: A411-A412
Meeting Room: A402-A403
285 Andrew Young International Blvd NW
Atlanta, GA 30313


Graft-versus-host disease (GvHD) is a leading cause of morbidity and mortality among patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). An immune-mediated disorder, GvHD can manifest as an acute or chronic syndrome, each of which presents unique challenges for clinicians who encounter them. The clinical ramifications of these disorders and their rising incidence worldwide make it critical for hematologists who manage patients with hematological malignancies to maintain knowledge and competence concerning GvHD. During this activity, renowned experts will review and discuss aspects of GvHD important to cancer care providers, including its pathophysiology, assessment of patient risk for GvHD, diagnostic challenges, management recommendations, prevention and mitigation of adverse events, patient counseling considerations, and emerging therapeutic options. Additionally, the program will include a preview of GvHD data to be presented at the Annual Meeting.To help put information into its proper context, this program includes several interactive case-based faculty panel discussions and question-and-answer sessions.

Target Audience

This educational activity is intended for hematologists, medical oncologists, and other healthcare professionals interested in the latest advances in the treatment of patients with hematologic malignancies. Fellows, researchers, nurses, nurse practitioners, physician assistants, and other healthcare professionals interested in the treatment of patients with hematologic malignancies are also invited to attend.

Learning Objectives

After successful completion of this educational activity, participants should be better able to:

  • Summarize graft-versus-host disease (GvHD) pathogenesis and the evidence that informs best clinical practices to manage GvHD
  • Review current and prophylactic treatment regimens for GvHD
  • Describe current evidence regarding emerging therapies in the treatment of GvHD
  • Identify treatment-related risks associated with GvHD treatment strategies

Activity Chair

John F. DiPersio, MD, PhD
Virginia E. and Samuel J. Golman Professor
Chief, Division of Oncology
Deputy Director, Siteman Cancer Center
Washington University School of Medicine
St Louis, MO

Become a Member

Forgot Password?
Calendar of Events
Filter By